Hussain M - Search Results

1

Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.

Qian F, Wang J, Hartley R, Tao J, Haddadin R, Mathias N, Hussain M. Qian F, et al. Among authors: hussain m. Pharm Res. 2012 Oct;29(10):2765-76. doi: 10.1007/s11095-012-0695-7. Pharm Res. 2012. PMID: 22315020

2

Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.

Chen Y, Wang S, Wang S, Liu C, Su C, Hageman M, Hussain M, Haskell R, Stefanski K, Qian F. Chen Y, et al. Among authors: hussain m. Pharm Res. 2016 Oct;33(10):2445-58. doi: 10.1007/s11095-016-1969-2. Epub 2016 Jun 9. Pharm Res. 2016. PMID: 27283830

3

Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.

Chen H, Pui Y, Liu C, Chen Z, Su CC, Hageman M, Hussain M, Haskell R, Stefanski K, Foster K, Gudmundsson O, Qian F. Chen H, et al. Among authors: hussain m. J Pharm Sci. 2018 Jan;107(1):317-326. doi: 10.1016/j.xphs.2017.10.028. Epub 2017 Oct 26. J Pharm Sci. 2018. PMID: 29107047

4

Mechanistic investigation of Pluronic based nano-crystalline drug-polymer solid dispersions.

Qian F, Tao J, Desikan S, Hussain M, Smith RL. Qian F, et al. Among authors: hussain m. Pharm Res. 2007 Aug;24(8):1551-60. doi: 10.1007/s11095-007-9275-7. Epub 2007 Mar 23. Pharm Res. 2007. PMID: 17380258

5

Estimation of drug solubility in polymers via differential scanning calorimetry and utilization of the fox equation.

Haddadin R, Qian F, Desikan S, Hussain M, Smith RL. Haddadin R, et al. Among authors: hussain m. Pharm Dev Technol. 2009;14(1):18-26. doi: 10.1080/10837450802409370. Pharm Dev Technol. 2009. PMID: 18825543

6

Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?

Qian F, Huang J, Zhu Q, Haddadin R, Gawel J, Garmise R, Hussain M. Qian F, et al. Among authors: hussain m. Int J Pharm. 2010 Aug 16;395(1-2):232-5. doi: 10.1016/j.ijpharm.2010.05.033. Epub 2010 May 24. Int J Pharm. 2010. PMID: 20562003

7

pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.

Zhou R, Moench P, Heran C, Lu X, Mathias N, Faria TN, Wall DA, Hussain MA, Smith RL, Sun D. Zhou R, et al. Pharm Res. 2005 Feb;22(2):188-92. doi: 10.1007/s11095-004-1185-3. Pharm Res. 2005. PMID: 15783065

8

Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.

Qian F, Huang J, Hussain MA. Qian F, et al. J Pharm Sci. 2010 Jul;99(7):2941-7. doi: 10.1002/jps.22074. J Pharm Sci. 2010. PMID: 20127825

9

Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.

Chen Y, Wang S, Wang S, Liu C, Su C, Hageman M, Hussain M, Haskell R, Stefanski K, Qian F. Chen Y, et al. Among authors: hussain m. Mol Pharm. 2016 Aug 1;13(8):2787-95. doi: 10.1021/acs.molpharmaceut.6b00391. Epub 2016 Jul 1. Mol Pharm. 2016. PMID: 27337060

10

Mitigation of Adverse Clinical Events of a Narrow Target Therapeutic Index Compound through Modified Release Formulation Design: An in Vitro, in Vivo, in Silico, and Clinical Pharmacokinetic Analysis.

Good DJ, Hartley R, Mathias N, Crison J, Tirucherai G, Timmins P, Hussain M, Haddadin R, Koo O, Nikfar F, Fung NK. Good DJ, et al. Among authors: hussain m. Mol Pharm. 2015 Dec 7;12(12):4434-44. doi: 10.1021/acs.molpharmaceut.5b00624. Epub 2015 Nov 4. Mol Pharm. 2015. PMID: 26536519 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,550 results

Search Page

Filters